Recombinant MET (Telisotuzumab Biosimilar) antibody

Catalog No. ABIN7795055

This Humanized Monoclonal antibody specifically detects MET (Telisotuzumab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant MET (Telisotuzumab Biosimilar) antibody (ABIN7795055)

Target: MET (Telisotuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This MET (Telisotuzumab Biosimilar) antibody is un-conjugated

Application: ELISA

Product Details anti-MET (Telisotuzumab Biosimilar) Antibody

Purpose: Anti-MET(telisotuzumab biosimilar) mAb

Isotype: IgG1 kappa

Application Details

Application Notes: ELISA 1:5000-10000

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.

Target Details for MET (Telisotuzumab Biosimilar)

Target: MET (Telisotuzumab Biosimilar)

Alternative Name: telisotuzumab biosimilar

Target Type: Biosimilar

Background: ABT-700,hz224G11,MET

UniProt: P08581